- Well-established oncogene
- Driver of tumors
- May confer resistance to chemotherapy
- Cyclin D overexpression, accumulation, and mislocalization have been reported in cancers in both solid and hematological malignancies
- Cyclin D1 is the most commonly overexpressed in most cancers/tumors among D-type cyclins.
- Not only Cyclin D-CDK4/6 holoenzymes but also D-type cyclins independently of their catalytic subunit have been shown to play a role in driving cancer progression.
- Mutine models of oncogenesis have also supported the role of cyclin D in tumorigenesis.
Was this post helpful?
Let us know if you liked the post. That’s the only way we can improve.
1 thought on “Cyclin D in Cancer”